YM 16151-1
| Code | Size | Price |
|---|
| TAR-T35256-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
YM 16151-1 is a biochemical.
CAS:
103434-30-6
Formula:
C30H37N3O9
Molecular Weight:
583.638
Purity:
0.98
SMILES:
COC(=O)C1=C(C)NC(C)=C(C1c1cc(ccc1OCCCCNCC(O)COc1ccccc1)[N+]([O-])=O)C(=O)OC
References
Uchida W, Shibasaki K, Asano M, Takenaka T. Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent. Arch Int Pharmacodyn Ther. 1993 Jan-Feb;321:30-40. PubMed PMID: 8100704.
Uchida W, Shibasaki K, Matsuda Y, Asano M, Takenaka T. Cardiovascular effects of YM-16151-4: a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent in rats and dogs. J Cardiovasc Pharmacol. 1993 Aug;22(2):247-52. PubMed PMID: 7692165.
Uchida W, Shibasaki K, Asano M, Takenaka T. Antianginal effects of YM-16151-4 in various experimental angina models. J Cardiovasc Pharmacol. 1993 May;21(5):701-8. PubMed PMID: 7685438.
Uchida W, Shibasaki K, Asano M. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs. J Cardiovasc Pharmacol. 1992 Jan;19(1):60-8. PubMed PMID: 1375689.